Dueling Patents Partly Invalidated In Lexapro Row

Law360, New York (June 1, 2009, 12:00 AM EDT) -- In a blow to both sides battling over conflicting patents related to the antidepressant citalopram, a federal judge found two claims of plaintiff Infosint SA's patent obvious but also invalidated the first claim of the patent belonging defendant H. Lundbeck A/S after finding the company had suppressed or concealed its invention.

Judge Lewis A. Kaplan of the U.S. District Court for the Southern District of New York issued the mixed ruling Thursday that partially granted summary judgment to defendants Lundbeck and its partner Forest Laboratories Inc.,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.